Multidrug resistance-associated protein 2 (MRP2) transports glutathione conjugates, glucuronide conjugates, and sulfated conjugates of bile acids. In the present study, we examined the role of charged amino acids in the transmembrane domains of rat Mrp2, conserved among MRP families, using the isolated membrane vesicles from Sf9 cells infected with the recombinant baculoviruses. By normalizing the transport activity for compounds by that for estradiol 17␤-D-glucuronide (E 2 17␤G), it was indicated that the site-directed mutagenesis from Lys to Met at 325 (K325M) and from Arg to Leu at 586 (R586L) results in a marked reduction in the transport for glutathione conjugates [2,4-dinitrophenyl-S-glutathione (DNP-SG) and leukotriene (LT) C 4 ] without affecting that for 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridymethyl) benzothiazole glucuronide and taurolithocholate sulfate. In contrast to the reduced affinity for DNP-SG, the affinity for E 2 17␤G was increased severalfold in these mutant Mrp2s, suggesting the amino acids at 325 and 586 play an important role in distinguishing between glutathione and glucuronide conjugates. The comparable affinity for LTD 4 , LTE 4 , and LTF 4 in these mutant Mrp2s with that in wild-type Mrp2 indicates that recognition of LTC 4 metabolites by Mrp2 is different from that of LTC 4 . The transport activity for glutathione conjugate was retained on R586K, whereas no such complementary cationic amino acid effect was observed in K325R. In addition, R1206M and E1208Q exhibited the loss of transport activity for the tested compounds. The results of the present study demonstrate that the charged amino acids in the transmembrane domain of rat Mrp2 may play an important role in the recognition and/or transport of its substrates.
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Canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2 (cMOAT/MRP2) plays an important role in the biliary excretion of anionic compounds. In patients suffering from Dubin-Johnson syndrome, a defect in the expression of this protein has been demonstrated Paulusma et al., 1997; Toh et al., 1999; Tsujii et al., 1999) . The substrate specificity of Mrp2 has been determined in great detail by comparing transport across the bile canalicular membrane between normal and Mrp2-deficient rats (Keppler and König, 1997; Suzuki and Sugiyama, 1998) . Mrp2 substrates include glutathione conjugates [e.g., 2, 4-dinitrophenyl-S-glutathione (DNP-SG) and leukotriene (LT) C 4 ], glucuronide conjugates [e.g., estradiol 17-␤-D-glucuronide (E 2 17␤G)], sulfate conjugates of certain bile salts [e.g., taurolithocholate-3-sulfate (TLC-S)], and nonconjugated organic anions (e.g., methotrexate) (Keppler and König, 1997; Suzuki and Sugiyama, 1998) . As a homolog of MRP1, the cDNA for Mrp2/MRP2 has been cloned (Büchler et al., 1996; Paulusma et al., 1996; Taniguchi et al., 1996; Ito et al., 1997) and a functional analysis of the cloned cDNA product has been performed (Madon et al., 1997; Evers et al., 1998; Ito et al., 1998; van Aubel et al., 1998; Cui et al., 1999) . The substrate specificity of Mrp2/MRP2 is very similar to that of MRP1 (Gao et al., 1996; Keppler and König, 1997; Cole and Deeley, 1998; Suzuki and Sugiyama, 1998; .
More recently, rat and human Mrp3/MRP3 have been cloned as a homolog of MRP1 and 2 Kiuchi et al., 1998; Uchiumi et al., 1998; Kool et al., 1999) . Considering the fact that rat and human MRP3s are highly expressed on the basolateral membrane of rat and human liver under cholestatic/hyperbilirubinemic conditions Kool et al., 1999) , it is possible that Mrp3/MRP3 may compensate for the impaired function of cMOAT/MRP2 in the liver. Hirohashi et al. (1999) were the first to demonstrate that the substrate specificity of rat Mrp3 is markedly different from MRP1 and cMOAT/MRP2 in that although glucuronide conjugates, such as E 2 17␤G and E3040-glucuronide, or nonconjugated organic anions, such as methotrexate, are good substrates, glutathione conjugates, such as DNP-SG and LTC 4 , are poor substrates for Mrp3. A hydropathy plot analysis suggests that the structures of MRP1-3 are very similar.
The substrate recognition/transport by MRP1 has been studied in relation to its structure. MRP1 consists of 17 transmembrane domains (TMs) organized in three membrane-spanning domain regions [MSD1 (TM1-5), MSD2 (TM6 -11), and MSD3 (TM12-17)] . The function of MSD1 followed by a linker region, both of which are not present in MDR-type transporters, was studied using a series of 5Ј-truncated MRP1 molecules expressed in insect cells (Bakos et al., 1998; Gao et al., 1998) . They found that the linker region between MSD1 and 2, but not the MSD1 domain itself, is necessary for transporting LTC 4 . Moreover, a chimeric study of human MRP1 and mouse mrp1 expressed in human embryonic kidney 293 cells suggested that anthracycline resistance and the ability to transport E 2 17␤G is conferred by the COOH-terminal third of the protein (Stride et al., 1999) . Moreover, it has been reported that Fab fragments of monoclonal antibodies QCRL-2, -3, and -4, which recognize the conformation-dependent epitopes around NH 2 -proximal or COOHproximal nucleotide-binding domain (NBD) of MRP1, inhibit the ATP-dependent transport of LTC 4 without affecting the photolabeling of MRP with 8-azido- [␣- 32 P]ATP (Hipfner et al., 1999) .
The importance of the amino acid residues located in the membrane-spanning domains was previously demonstrated for MDR1 (Loo and Clarke, 1999) and CFTR (Sheppard and Welsh, 1999) ; e.g., alterations in amino acid residues in TM6 and 12 of MDR1 affects the function of this protein (Loo and Clarke, 1999) . For CFTR, a cationic charge in the side chain at amino acid 352 (Arg), a residue flanking the predicted cytoplasmic end of the TM6 segment, is a determinant for ion selectivity in CFTR (Guinamard and Akabas, 1999) . However, there has been no report concerning the amino acid residues involved in the substrate recognition/transport by MRP families. Considering the fact that the substrates for MRP families are composed of a relatively bulky hydrophobic part and a hydrophilic part possessing at least one anionic charge, charged amino acids, particularly cationic amino acids, in the membrane-spanning domain may play an important role in the recognition/transport of organic anions. To obtain insight into the interaction between MRP families and their substrates, we have used rat Mrp2 as a model protein for MRP families. In the present report, the role of charged amino acids in the membrane-spanning domain was analyzed in detail. [glycine-2- 3 H]glutathione (PerkinElmer Life Science Products), 1-chloro-2,4-dinitrobenzene, and glutathione Stransferase (Sigma Chemical, St. Louis, MO) as described previously (Kobayashi et al., 1990) , and the purity (Ͼ90%) was checked by thin layer chromatography. [
Experimental Procedures
14 C]E3040-glucuronide was kindly provided from Eisai Co. Ltd. (Tokyo, Japan) and [
3 H]TLC-S (30.3 Ci/mmol) was kindly provided by Dr. Takikawa in Teikyo University (Tokyo, Japan). LTC 4 , LTD 4 , LTE 4 , LTF 4 , E 2 17␤G, ATP, AMP, creatine phosphate, and creatine phosphokinase were from Sigma Chemical. BigDye terminator was purchased from PerkinElmer (Foster City, CA). Mutagenic primers and sequencing primers were obtained from Nissinbo Industries Inc. (Tokyo, Japan). Sf9 cells were maintained as a suspension culture at 27°C with serum-free Excel 420 (Nichirei Corporation, Tokyo, Japan) supplemented with an antibiotic-antimycotic mixture (LifeTechnologies, Tokyo, Japan).
Plasmid Construction. Mrp2 in pBluescript SK(Ϫ) (Stratagene, La Jolla, CA), used previously to generate a vector for transfection of NIH3T3, included 35 nucleotides of the 5Ј-untranslated region of Mrp2 mRNA . To eliminate the potential activity of this relatively GC-rich region to reduce the translational efficiency in insect cells, the 5Ј end of the Mrp2-coding sequence was amplified by polymerase chain reaction using the forward primer [5Ј-dcagaAGATCTaggagAGCGCTatggacaag-3Ј, which includes BglII (underline) and Aor51H I (double underline) sites] and the reverse primer (5Ј-dTTGGTTATAGAAGATCTCTTGG-3Ј). A polymerase chain reaction product of approximately 210 bases was generated and subsequently digested at the BglII sites located in the forward and reverse primer sequences. This fragment was inserted into the Mrp2 expression cassette followed by removal of the BglII fragment (one is from the multiple cloning site of the vector and the other is from the inside the Mrp2 sequence at nucleotide 171) to produce a new expression cassette Mrp2-Aor51H-SalI. A 4.9-kilobase Aor51HI-SalI fragment containing the full-length coding region flanked by an untranslated sequence of 3 and 222 nucleotides at the 5Ј and 3Ј ends, respectively, was isolated from this modified vector and connected to the BamHISmaI linker at the 5Ј end and subsequently inserted into the BamHI and SalI site of the donor plasmid pFASTBAC1 (Life Technologies) downstream from the polyhedrin promoter.
Site-Directed Mutagenesis. The KpnI-XbaI fragment, including the 5Ј end deleted Mrp2 cassette described above, was digested from the modified Mrp2/pBluescript SK(Ϫ) and subsequently inserted into the KpnI-XbaI site of pKF18k. Mutagenesis was performed using the Mutan-Express Km site-directed mutagenesis system (Takara Shuzo Co. Ltd., Kyoto, Japan). Mutated Mrp2 was recovered as Aor51HI-SalI fragments and ligated to BamHI-SmaI linker at the 5Ј end to be cloned into the BamHI-SalI site of the recombinant donor plasmid pFASTBAC1 (Life Technologies).
Production of Recombinant Baculovirus. The recombinant donor plasmids were used to transform Escherichia coli-competent DH10BAC cells (Life Technologies), which contain the parent bacmid and a helper plasmid. Recombinant bacmids were selected on LB plates containing 50 mg/ml kanamycin, 7 g/ml gentamicin, 10 g/ml tetracycline, 300 g/ml 5-bromo-4-chloro-3-indolyl-D-galactoside, and 40 g/ml isopropylthio-D-galactoside. The purified recombinant bacmids were transfected into Sf9 cells using CELLFECTIN Reagent (Life Technologies). Three days later, supernatant was recovered and used to infect fresh Sf9 cells. Finally, amplified virus supernatants were prepared after two cycles of this infection procedure. Their titer was determined and the virus was stored at 4°C.
Infection of Recombinant Baculovirus and Membrane Vesicle Preparation. The Sf9 cell suspension was poured into a culture dish and allowed to stand for 1 h at 27°C. During this incubation, the cells were allowed to attach to the dish. The medium was changed to fresh medium supplemented with 5% fetal bovine serum and respective recombinant baculoviruses. In our experiments, the multiplicity of infection was 1 to 5. For control experiments, Sf9 cells were infected with a baculovirus encoding the green fluorescent protein (GFP) (GFP-control). Cells were harvested 60 to 72 h after infection and, subsequently, membrane vesicles were isolated from 1 to 2 ϫ 10 7 Sf9 cells using the standard method described previously with some modifications (Muller et al., 1994) . Briefly, cells were diluted 40-fold with hypotonic buffer (1 mM Tris-HCl, 0.1 mM EDTA, pH 7.4, at 4°C) and stirred gently for 1 h on ice in the presence of 2 mM phenylmethylsulfonyl fluoride, 5 g/ml leupeptin, 1 g/ml pepstatin, and 5 g/ml aprotinin. The cell lysate was centrifuged at 100,000g for 30 min at 4°C, and the resulting pellet was suspended in 10 ml of isotonic TS buffer (10 mM Tris-HCl, pH 7.4 at 4°C/250 mM sucrose) and homogenized with Dounce B homogenizer (glass/glass, tight pestle, 30 strokes). The crude membrane fraction was layered on top of a 38% (w/v) sucrose solution in 5 mM Tris-HEPES, pH 7.4 at 4°C, and centrifuged in a Beckman SW41 rotor at 280,000g for 45 min at 4°C. The turbid layer at the interface was collected, diluted to 23 ml with TS buffer, and centrifuged at 100,000g for 30 min at 4°C. The resulting pellet was suspended in 400 l of TS buffer. Vesicles were formed by passing the suspension for 30 times through a 25-gauge needle with a syringe. The membrane vesicles were finally frozen in liquid nitrogen and stored at Ϫ80°C until use. Protein concentrations were determined by the Lowry method.
Transport Study. The transport study was performed using the rapid filtration technique described previously . Briefly, 16 l of transport medium [10 mM Tris, 250 mM sucrose, 10 mM MgCl 2 , 5 mM ATP or AMP, and ATP-regenerating system (10 mM creatine phosphate, 100 g/ml creatine phosphokinase), pH 7.4], containing radiolabeled compounds with or without unlabeled substrate, was preincubated at 37°C for 3 min and then rapidly mixed with 4 l of membrane vesicle suspension (10 g of protein). The transport reaction was stopped by the addition of 1 ml of ice-cold buffer containing 250 mM sucrose, 0.1 M NaCl, 10 mM Tris-HCl (pH 7.4). The stopped reaction mixture was filtered through a 0.45-m HVWP filter (Millipore Corp., Bedford, MA) and then washed twice with 5 ml of stop solution. Radioactivity retained on the filter was determined using a liquid scintillation counter (LSC-3500; Aloka Co., Tokyo, Japan).
The initial uptake rate of a tracer amount of each ligand was determined in the presence of ATP or AMP; 3 H]TLC-S (16.5 nM at 5 min). The relative transport activity of each ligand by mutant Mrp2 was calculated by subtracting the uptake into vesicles containing GFP from that into vesicles containing the mutant Mrp2 in the presence of ATP. This is possible because the same transport activity was observed in the absence of ATP in both GFP-and Mrp2-expressing vesicles (data not shown).
The relative uptake (R rel ) rate was calculated for each ligand using the equation R rel ϭ (Uptake mut Ϫ Uptake GFP ) / (Uptake wild type Ϫ Uptake GFP ), where Uptake mut , Uptake wild type , and Uptake GFP represent the initial uptake rate (pmol/min/mg) of each ligand into mutant Mrp2s, wild-type Mrp2, and GFP-containing vesicles in the presence of ATP, respectively. The calculated R rel values were then normalized using the equation RЈ ϭ R rel (ligand) / R rel (E 2 17␤G), where R rel (ligand) represents the R rel value for each ligand (TLC-S, DNP-SG, LTC 4 , and E3040-glucuronide), and R rel (E 2 17␤G) represents the R rel value for E 2 17␤G. Thus, RЈ represents the relative transport activity of each ligand into the wild-type and mutant Mrp2-expressing vesicles normalized with respect to the transport of E 2 17␤G into the respective membrane vesicles. In the present report, the results of the transport studies are given as the mean Ϯ S.E. with the number of determinations unless otherwise noted.
Western Blot Analysis. Membrane vesicles from Sf9 cells were loaded on to a 8.5% polyacrylamide slab gel containing 0.1% SDS and then transferred on to a Pall Fluoro Trans W membrane filter (Pall Gelman Sciences, Ann Arbor, MI) by electroblotting. The filter was blocked with Tris-buffered saline containing 0.05% Tween 20 and 5% bovine serum albumin for 2 h at room temperature and probed overnight at room temperature with polyclonal anti-Mrp2 antibody raised against the upstream region of carboxyl-terminal NBD (amino acid residues 1272-1285) (CP-2 antibody, supplied by Dr. Nakayama in Kumamoto University, Kumamoto, Japan) diluted with Tris-buffered saline containing 0.05% Tween 20 and 0.5% bovine serum albumin (1:1000). Antibody was visualized with 125 I-anti-rabbit antibody (Amersham Pharmacia Biotech, Uppsala, Sweden), followed by exposure to Fuji imaging plates (Fuji Photo Film Co., Ltd., Kanagawa, Japan) for 3 h at room temperature, and analyzed with an imaging analyzer (BAS 1500; Fuji Photo Film Co., Ltd.).
Results
Charged Amino Acids in the Transmembrane Domains Conserved in the MRP Family. Human MRP1 is composed of 17 TM helices to form three membrane-spanning domains (MSD1, 2, and 3) connected by poorly conserved linker regions (L 0 and L 1 ) and highly conserved nucleotide binding domains (NBD1 and NBD2) (Bakos et al., 1996; Hipfner et al., 1997) . A hydropathy plot analysis of rat Mrp2 with the Kite & Doolittle algorithm suggested a similar profile to that of human MRP1. Moreover, similar profiles were obtained for other MRP members, including mouse Mrp1 (Stride et al., 1996) , human (Taniguchi et al., 1996) and rabbit MRP2 (van Aubel et al., 1998) , and human Kiuchi et al., 1998) and rat MRP3 . A schematic diagram illustrating the structure is shown in Fig. 1A and this was predicted from the hypothesis that rat Mrp2 also has the same membrane topology and domain organization as human MRP1. To determine the key amino acid residues for recognition and/or transport of organic anions via MRP families, the charged amino acids in the transmembrane domains of rat Mrp2 were examined first. Because it is difficult to predict whether amino acids are located inside or outside the lipid bilayer at the boundary, we selected 47 cationic amino acids (i.e., Lys, Arg, and His) within and/or around the TM of rat Mrp2. Alignment of the extended TMs (TM6, 11, 13, 14, 16, and 17) , in which conserved charged amino acids were found, is shown in Fig. 1B . Among them, cationic amino acids, Arg or Lys at 308 and 325 (TM6), 586 (TM11), 1019 (TM13), 1201 (TM16), and 1226 (TM17), were found to be conserved among MRP1-3. The transport properties of MRP1 and 2 are different from those of Mrp3 in that the former accept both glutathione conjugates and glucuronide conjugates as good substrates Cui et al., 1999) , whereas the latter accepts only glucuronide conjugates as good substrates (Hirohashi et al., 1999) . The difference in the substrate specificity of these MRP families prompted us to find additional two cationic amino acids at 1096 (TM14) and 1206 (TM16), which are conserved in MRP1 and 2, but not in MRP3. Moreover, anionic amino acids conserved in MRP1-3 were found at 329 (TM6) and 1208 (TM16).
Site-directed mutagenesis was performed on these 10 charged amino acids, which are partially or fully conserved among the MRP families. Moreover, the cationic amino acid at 320 (TM6), which was found only in MRP2, was selected as a negative control for this site-directed mutagenesis analysis.
In the present study, cationic amino acids substituted by 
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Met resulted in the production of the corresponding mutant Mrp2s. These include K308M, K320M, K325M, R1019M, R1201M, R1206M, and R1226M. For R586 and R1096, Arg was substituted by Leu (R586L and R1096L). The anionic amino acid residues Asp at 329 and Glu at 1208 were substituted by the corresponding neutral amino acids to produce D329N and E1208Q, respectively. In addition, we have introduced further extensive mutations in Mrp2 cDNA, such as K325R, R586K, and R586I, and D329E to assess the effect of substitution by other amino acids in these positions. Expression of Wild-Type and Mutant Mrp2 in Sf9 Cells. The expression of a series of mutant Mrp2s in the infected cells was confirmed by Western blot analysis. The antibody recognized an ϳ190-kDa band in the membrane vesicles from Sprague-Dawley rat liver (data not shown). Slightly shorter bands of ϳ175 kDa were detected in membrane vesicles isolated from Sf9 cells infected with wild-type or mutant Mrp2 cDNA carrying baculoviruses, but not in GFP-control vesicles (Fig. 2) . The difference in the molecular mass may be accounted for by the lower degree of sugar modification in the insect cells, as reported for rabbit Mrp2 expressed in Sf9 cells (van Aubel et al., 1998) .
Densitometric analysis revealed up to 12-fold difference in the expression levels among mutant Mrp2s, except for R1201M and R1226M, whose expression was below the limit of detection. Alteration of the translational efficiency and/or stability of the protein caused by the amino acid substitution may be one reason for the difference in expression level between mutant Mrp2s.
Transport of Mrp2 Substrates into Membrane Vesicles from Sf9 Cells. Previously described Mrp2 substrates were subjected to an analysis of their transport activity. ATP-dependent uptake of typical substrates for Mrp2 into wild-type Mrp2-expressing membrane vesicles was significantly enhanced compared with GFP-control vesicles; Alterations in the substrate specificity were found in some mutant Mrp2s (Fig. 3) . The relative transport activities (RЈ values) of all compounds examined were not affected in K308M, K320M, and R1096L compared with the wild-type Mrp2 (Fig. 3) . Mrp2-dependent transport of all substrates was not detectable in R1206M and E1208Q (data not shown), whereas adequate expression of these mutated Mrp2 molecules was demonstrated in the Western blot (Fig. 2) . Most interestingly, a marked reduction in the relative transport activity for DNP-SG and LTC 4 transport was observed in K325M and R586L, whereas those for E3040-glucuronide and TLC-S were not significantly different from those in wild-type Mrp2 (Fig. 3) . Although the absolute transport activity for E 2 17␤G, E3040-glucuronide and TLC-S decreases to some extent in D329N (data not shown), relatively greater reduction in the transport activity for glutathione conjugates was observed in D329N (Figs. 3 and 8) .
Concentration Dependence of E 2 17␤G and DNP-SG Uptake. To determine the changes in the affinity of glutathione and glucuronide conjugates for K325M and R586L, whose transport activity of glutathione conjugates was significantly reduced (Fig. 3) , the concentration dependence in the transport of E 2 17␤G and DNP-SG was determined. The initial uptake rate of each compound was determined at several concentrations of E 2 17␤G (0.1-75 M) and DNP-SG (2.4-600 M) and was used to calculate the K m values for wild-type Mrp2, K325M, and R586L ( Fig. 4 ; Table 1 ). The K m values for wild-type Mrp2, K325M, and R586L-mediated transport of E 2 17␤G were 3.91 Ϯ 0.93, 0.40 Ϯ 0.05, and 1.40 Ϯ 0.46 M (mean Ϯ computer calculated S.D.), respec- (Bakos et al., 1996; Hipfner et al., 1997) . Dots represent the approximate location of amino acid residues that underwent site-directed mutagenesis. B, detailed alignment of TM of Mrp2 with respective TM number is shown in comparison with human and mouse MRP1; human, rat, and rabbit MRP2; and human and rat MRP3. The amino acid number is shown only for rat Mrp2. Predicted TMs are underlined. Dots represent the location of amino acid residues where mutation was introduced. tively ( Fig. 4A ; Table 1 Fig. 5B ; Table 1 ). Because tracer concentrations of isotopically labeled ligands were used in the present study, these IC 50 values represent the respective K i values. The increase in the affinity of E 2 17␤G for R586L and the reduction in the affinity of DNP-SG for both K325M and R586L were also confirmed in these mutual inhibition experiments ( Fig. 5 ; Table 1 ).
Structural Requirement for the Recognition of Glutathione Conjugate. To obtain insight into the relationship between structural differences in the glutathione moiety and the transport activity, the inhibitory effect of a series of leukotriene derivatives on the uptake of E 2 17␤G was studied in wild-type Mrp2, K325M, and R586L. In wild-type Mrp2, the uptake of a tracer amount of (Fig. 3) . In contrast, the inhibitory potency was not significantly altered in K325M and R586L for other leukotriene derivatives, including LTD 4 , LTE 4 , and LTF 4 , and MK571 (Table 2) . Also, the ATP-dependent transport of LTC 4 was lost in both mutant Mrp2s, although those of LTD 4 and LTE 4 in mutant Mrp2s remained to significant levels (Fig. 7) .
Compensation of the Charged Amino Acid at 325, 329, and 586. To further examine the requirement of charged amino acids at 325, 329, and 586 for the transport activity of glutathione conjugates, we constructed K325R, D329E, R586K, and R586I. The expression level of mutant Mrp2 proteins was similar among these mutant Mrp2s and wild-type Mrp2 (data not shown). ATP-dependent uptake of [ 3 H]E 2 17␤G was detected in these mutant Mrp2s, although Fig. 2 . Western blot analysis of wild-type and mutant Mrp2s. Membrane vesicles (50 g of protein) were separated on an 8.5% polyacrylamide slab gel containing 0.1% SDS. The fractionated proteins were transferred on to a membrane filter by electroblotting and wild-type and mutant Mrp2s were detected by polyclonal anti-Mrp2 antiserum. the absolute values were not identical among these mutant Mrp2s and wild-type Mrp2 (Fig. 8) 17␤G was reduced in K325R, K325M, R586I, R586L, D329E, and D329N, whereas no reduction was observed in R586K (Fig. 8) .
Discussion
Although the results of previous transport studies with isolated bile canalicular membrane vesicles (CMVs) and membrane vesicles expressing Mrp2 indicated that both of the glutathione conjugates and glucuronide conjugates are substrates for Mrp2 (Keppler and Konig, 1997; Suzuki and Sugiyama, 1998) , there was no direct evidence showing that these conjugates were indeed recognized by exactly the same recognition site. In the present study, we examined the mechanism for the transport/recognition of ligands by using the membrane vesicles isolated from Sf9 cells expressing the wild-type and mutant Mrp2s, particularly focusing on the role of charged amino acids located in the transmembrane domains. Transport activity of ligands by mutant Mrp2s was shown as the relative transport activity (RЈ) after normalization by that of E 2 17␤G; although it is better to normalize the uptake values in terms of the expression levels of mutant Mrp2 proteins, it is difficult to quantitatively determine the protein levels in an exact manner by Western blot analyses. Because our major purpose is to see the change in the substrate specificity of rat Mrp2 between glutathione conjugates and glucuronide conjugates, the uptake values of each ligand were normalized in terms of the uptake values of a standard compound. As a standard compound, we chose E 2 17␤G, because this compound is transported even by some of the mutant Mrp2s (K325M, D329N, and R586L), which do not transport glutathione conjugates. However, this normalization does not necessarily correct for the expression levels of mutant Mrp2 proteins, because the uptake of E 2 17␤G is affected not only by the protein levels but also by the kinetic parameters for E 2 17␤G (Table 1) . After this normalization, we found a selective loss of transport activity for glutathione conjugates in K325M and R586L (Fig. 3) , whereas an increase in the affinity for glucuronide conjugates was observed in these mutant Mrp2s (Figs. 4 and 5) . Collectively, it was suggested that glutathione conjugates and glucuronide conjugates are not necessarily recognized by the same mechanism. These results are consistent with the observations in the kinetic studies; e.g., the IC 50 values of DNP-SG on the transport of E 2 17␤G are different from K m values of DNP-SG for both of wild-type and mutant Mrp2 (R586L) ( Table 1) .
The results shown in Figs. 3, 7, and 8 suggest that the amino acid residues at 325 and 586 play an important role in discriminating each conjugate. The fact that the transport activity for LTC 4 is maintained in R586K, but not in R586L or R586I (Fig. 8) , indicates the requirement for a cationic charge at 586 to be able to recognize glutathione conjugates. In contrast, Arg and Glu could not compensate for the function of Lys at 325 and Asp at 329, respectively. These results demonstrate that functional compensation by cationic amino 3 H]DNP-SG (50 nM; B) was examined at 37°C in membrane vesicles expressing wild-type Mrp2 (f), K325M (F), and R586L (OE). Each symbol represents the Mrp2-dependent uptake determined by subtracting the uptake into GFP-control vesicles from that into Mrp2-expressing vesicles in the presence of ATP. Each point and bar represents the mean Ϯ S.E. of triplicate determinations. acid is possible at Arg 586, but not at Lys 325. In addition, Glu 329 was not functionally substituted by anionic amino acid. These results may be accounted for by the hypothesis that these cationic and anionic amino acids are necessary parts of the functional structure for the recognition/transport of glutathione conjugates. Another possible hypothesis is that the cationic side chain of amino acid residues may interact directly with the anionic charge of glutathione conjugates. The former hypothesis has already been proposed for many membrane proteins, including transporters and ion channels (Merickel et al., 1997; Gupta et al., 1998) . For example, the salt bridge between Lys in TM2 and Asp in TM11 of the vesicular monoamine transporter has been shown to be important for transport activity (Merickel et al., 1997) . Substitution of either Lys by Ala or Asp by Ala resulted in the loss of transport activity for monoamines (Merickel et al., 1997) . The same mechanism may hold for Mrp2; in Mrp2, Asp at 329 is adjacent to Lys at 325 at intervals of four amino acid residues in the same transmembrane helices (TM6). Interaction of the side chains of K325 and D329 is plausible, because a hydrogen bond can be formed between the carbonyl oxygen and amino hydrogen of the amino acids at position n and n ϩ 4 in an ␣-helix. This hypothesis is further supported by the fact that both K325M and D329N lost transport activity for glutathione conjugates, but not for other conjugates (Fig. 3) . Similar conformational changes may have occurred in these two mutant Mrp2s due to the disappearance of a salt bridge between K325 and D329. Although R586 plays a critical role in transporting glutathione conjugates (Fig. 3) , there is no candidate anionic amino acid able to form a salt bridge around R586 in the same helix. Interaction with distant amino acid residues in another transmembrane helix or direct interaction with the anionic charge of the ligand molecule may be one of the roles of R586. Recently, Stride et al. (1999) described the importance of the carboxyl-terminal domain of MRP1 in the transport of E 2 17␤G using chimeric protein of human and mouse MRP1. They suggested that the recognition site for LTC 4 and E 2 17␤G in MRP1 is not absolutely equivalent, based on the finding that comparable transport activity for LTC 4 is observed in wild type and a series of MRP1 chimeras, whereas the extent of transport of E 2 17␤G was very different among mutants (Stride et al., 1999) . No information about the recognition site for the glutathione conjugate was obtained from the human and mouse MRP1 chimera studies, because sim- 
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at ASPET Journals on September 20, 2017 molpharm.aspetjournals.org ilar transport activity for LTC 4 was observed in both orthologs (Stride et al., 1999) . Our results are the first demonstration of the importance of TM6 and TM11, particularly the charged amino acids in these helices, for the recognition/ transport of the glutathione conjugate. However, we cannot determine the requirement of other amino acid residues, as far as the function of Mrp2 is concerned, due to the limitations in the site-directed mutagenesis approach. Chimeric studies between Mrp2 and Mrp3 would provide an answer to this question.
The mechanism of substrate recognition was further investigated using a series of leukotriene derivatives. As shown in Fig. 6 , LTD 4 , LTE 4 , and LTF 4 are the sequential metabolites of LTC 4 ; LTD 4 is the metabolite of LTC 4 produced by ␥-glutamyl transpeptidase, containing the Cys-Gly-conjugate structure. LTE 4 is the metabolite produced from LTD 4 by dipeptidase, containing the Cys-conjugate structure (Fig. 6) . Finally, LTF 4 is produced from LTE 4 by ␥-glutamyl transpeptidase to form Glu-Cys-conjugate structure (Fig. 6 ). In addition, MK571 is an analog of LTD 4 (Fig. 6) . Using rat CMVs, the transport activity of LTD 4 and LTE 4 was determined to be 46 and 11% that of LTC 4 , respectively (Ishikawa et al., 1990) . This is also compatible with the rank order of MRP1-mediated transport (Jedlitschky et al., 1996) . LTD 4 and LTE 4 were also transported into wild-type Mrp2-expressing membrane vesicles in an ATP-dependent manner (Fig. 7) . The initial velocity of the uptake of LTD 4 and LTE 4 by wild-type Mrp2 was 7.4 Ϯ 0.3 and 1.8 Ϯ 0.1% (mean Ϯ S.E., n ϭ 3) that of LTC 4 , respectively (Fig. 7) , which was one-sixth of those reported in CMVs (Ishikawa et al., 1990 ).
The inhibition constants (IC 50 ) of LTD 4 and LTE 4 for the uptake of E 2 17␤G into wild-type Mrp2 [5.48 Ϯ 0.98 and 9.83 Ϯ 1.4 M (mean Ϯ calculated S.D.), respectively (Table  2) ] were similar to the previously reported K m values in CMVs (1.5 and Ͼ10 M, respectively) (Ishikawa et al., 1990) . Although there is no published information on the affinity of LTF 4 for MRP families, LTF 4 has a low inhibitory potency as LTD 4 and LTE 4 , compared with LTC 4 (Table 2 ). The IC 50 values of these LT derivatives, except for LTC 4 , were similar in K325M, R586L, and wild-type Mrp2 (Table 2) . Together with the finding that the transport activity for LTD 4 and LTE 4 , but not for LTC 4 , was retained in K325M and K586L (Fig. 7) , these results indicate a difference in the mechanism of recognition/transport by Mrp2 among LTC 4 and its sequential metabolites. Moreover, the cationic side-chains of K325 or R586 may not directly interact with the anionic charges of glutamic acid or glycine of the intact glutathione moiety, or those of glucuronide or sulfate conjugates.
In conclusion, we have demonstrated the important role played by charged amino acid residues in TM6 and TM11 for the transport of glutathione conjugates. These findings provide important information about the transport mechanism of MRP families. While this article was being considered for publication, Ryu et al. (2000) independently indicated that several charged amino acids in human MRP2 TM domains are involved in the transport activity of glutathione methyfluorescein. 
